المؤلفون: 't Hart JWH; Department of Surgery, Erasmus University Rotterdam, Rotterdam, Zuid-Holland, The Netherlands j.hart@franciscus.nl.; Department of Surgery, Franciscus Gasthuis en Vlietland, Rotterdam, Zuid-Holland, The Netherlands., Noordman BJ; Department of Surgery, Erasmus University Rotterdam, Rotterdam, Zuid-Holland, The Netherlands.; Department of Surgery, Franciscus Gasthuis en Vlietland, Rotterdam, Zuid-Holland, The Netherlands., Palsgraaf-Huisbrink J; Hospital Pharmacy, Franciscus Gasthuis en Vlietland, Rotterdam, Zuid-Holland, The Netherlands., Dunkelgrun M; Department of Surgery, Franciscus Gasthuis en Vlietland, Rotterdam, Zuid-Holland, The Netherlands., Zengerink HF; Department of Surgery, Franciscus Gasthuis en Vlietland, Rotterdam, Zuid-Holland, The Netherlands., Birnie E; Statistics and Education, Franciscus Gasthuis en Vlietland, Rotterdam, The Netherlands.; Surgery, University Medical Centre Groningen, Groningen, Groningen, The Netherlands., van Det MJ; Surgery, Ziekenhuisgroep Twente, Almelo, Overijssel, The Netherlands., Boerma EG; Surgery, Zuyderland Medical Centre Heerlen, Heerlen, Limburg, The Netherlands., de Castro SMM; Surgery, OLVG Locatie West, Amsterdam, North Holland, The Netherlands., Hazebroek EJ; Surgery, Rijnstate Hospital, Arnhem, Gelderland, The Netherlands.; Department of Surgery, Wageningen University and Research, Wageningen, Gelderland, The Netherlands., Langenhoff BS; Department of Surgery, Elisabeth-TweeSteden Ziekenhuis, Tilburg, Noord-Brabant, The Netherlands., Verhoef C; Department of Surgery, Erasmus University Rotterdam, Rotterdam, Zuid-Holland, The Netherlands., Apers JA; Department of Surgery, Franciscus Gasthuis en Vlietland, Rotterdam, Zuid-Holland, The Netherlands.

المصدر: BMJ open [BMJ Open] 2024 May 06; Vol. 14 (5), pp. e078853. Date of Electronic Publication: 2024 May 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Clinical Trial Protocol

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

مواضيع طبية MeSH: Tranexamic Acid*/administration & dosage , Tranexamic Acid*/therapeutic use , Gastric Bypass*/adverse effects , Gastric Bypass*/methods , Obesity, Morbid*/surgery , Antifibrinolytic Agents*/administration & dosage , Antifibrinolytic Agents*/therapeutic use, Humans ; Double-Blind Method ; Postoperative Hemorrhage/prevention & control ; Postoperative Hemorrhage/etiology ; Randomized Controlled Trials as Topic ; Female ; Multicenter Studies as Topic ; Adult ; Netherlands ; Clinical Trials, Phase III as Topic ; Male

المؤلفون: Schols AMR; Department of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, the Netherlands., Meijs E; Department of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, the Netherlands., Dinant GJ; Department of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, the Netherlands., Stoffers HEJH; Department of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, the Netherlands., Krekels MME; Zuyderland Medical Centre, Sittard, the Netherlands.; MCC Omnes Centre for Diagnostics and Innovation, Sittard, the Netherlands., Cals JWL; Department of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, the Netherlands.

المصدر: BMJ open [BMJ Open] 2019 May 28; Vol. 9 (5), pp. e026846. Date of Electronic Publication: 2019 May 28.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

مواضيع طبية MeSH: General Practitioners*, Antifibrinolytic Agents/*therapeutic use , Fibrin Fibrinogen Degradation Products/*therapeutic use , Practice Patterns, Physicians'/*statistics & numerical data , Venous Thromboembolism/*drug therapy, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Netherlands ; Primary Health Care/methods ; Treatment Outcome ; Young Adult